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Edited by Robert BaroukiAbstract Adipokines are involved in the obesity-induced
chronic inﬂammatory response that plays a crucial role in the
development of obesity-related pathologies such as type II diabe-
tes and atherosclerosis. We here demonstrate that capsaicin, a
naturally occurring phytochemical, can suppress obesity-induced
inﬂammation by modulating adipokine release from and macro-
phage behavior in obese mice adipose tissues. Capsaicin inhibited
the expressions of IL-6 and MCP-1 mRNAs and protein release
from the adipose tissues and adipocytes of obese mice, whereas it
enhanced the expression of the adiponectin gene and protein. The
action of capsaicin is associated with NF-jB inactivation and/or
PPARc activation. Moreover, capsaicin suppressed not only
macrophage migration induced by the adipose tissue-conditioned
medium, but also macrophage activation to release proinﬂamma-
tory mediators. Capsaicin may be a useful phytochemical for
attenuating obesity-induced inﬂammation and obesity-related
complications.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Proinﬂammatory mediator1. Introduction
Obesity is characterized by a chronic inﬂammatory state and
obesity-induced inﬂammation is considered to be closely asso-
ciated with obesity-related pathologies such as type II diabetes
and cardiovascular diseases. Adipokines, which are biologi-
cally active molecules secreted from adipose tissues or adipo-
cytes, play major roles in the regulation of food intake,
insulin sensitivity, energy metabolism, and the vascular micro-
enviroment [1,2]. Among adipokines, tumor necrosis factor-
alpha (TNF-a) [3], interleukin-6 (IL-6) [4], monocyte
chemoattractant protein-1 (MCP-1) [5], and adiponectin [6]
are strongly associated with obesity-induced inﬂammation
and obesity-related pathologies. The circulation levels of
TNF-a, IL-6, and MCP-1 positively correlate with the levels*Corresponding author. Fax: +82 52 259 1699.
E-mail address: rinayu@ulsan.ac.kr (R. Yu).
0014-5793/$32.00  2007 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2007.07.082of the inﬂammatory markers such as the C-reactive protein
[7,8], whereas adiponectin negatively correlates with it [1].
The dysregulation of adipokine release may result in the
chronic inﬂammatory condition observed in obesity and trig-
ger the development of obesity-related pathologies [1,9,10].
For example, TNF-a and IL-6 impair insulin signaling by sup-
pressing the expression of insulin-sensitive glucose transport 4
and insulin receptor substrate-1 [11–14]. MCP-1 decreases
insulin-stimulated glucose uptake rate and the expression
levels of adipogenic genes [15]. MCP-1-deﬁcient mice do not
develop atherosclerosis [16,17] and exhibit improved insulin
sensitivity [5,18]. Recent studies have shown that adipose tis-
sue-derived MCP-1 induces macrophage inﬁltration into adi-
pose tissues and thus augments the inﬂammatory response in
obesity [15,19,20]. On the other hand, adiponectin is consid-
ered to improve insulin sensitivity by upregulating the expres-
sion of insulin receptor substrate-1 in skeletal muscles [21], and
to attenuate the development of atherosclerosis by suppressing
the expression of adhesion molecules in vascular endothelial
cells, and inhibiting the accumulation of monocyte/macro-
phage-derived foam cells in the vascular wall [1,22]. These ﬁnd-
ings suggest that the dysregulation of the release of these
adipokines is critical for the development of obesity-related
pathologies; thus, the modulation of adipokines is a useful
strategy for preventing not only obesity-induced inﬂammation,
but also the development of obesity-related pathologies.
Studies have shown that anti-inﬂammatory agents including
phytochemicals are eﬀective for the treatment or control of
chronic inﬂammatory conditions such as rheumatism, asthma,
atherosclerosis, type II diabetes, and cancer [10,23–25]. How-
ever, little is known whether anti-inﬂammatory phytochemi-
cals can suppress obesity-induced inﬂammation. Capsaicin, a
spicy ingredient of hot peppers, elicits anti-inﬂammatory prop-
erties. Capsaicin inhibits the development of carrageen-
induced paw inﬂammation and adjuvant-induced arthritis
[26,27], as well as ethanol-induced inﬂammation by inhibiting
the release of proinﬂammatory mediators [28]. Moreover, our
previous study has also demonstrated that capsaicin inhibits
the inﬂammatory responses of macrophages by inhibiting
IjB-a degradation [29]. In this study, we tested the hypothesis
that the anti-inﬂammatory activity of capsaicin can be used
for improving obesity-induced inﬂammation. We examined
whether capsaicin modulates the production of adipokinesblished by Elsevier B.V. All rights reserved.
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sues and isolated adipocytes, and whether capsaicin alters
inﬂammatory responses of obese adipose tissue macrophages.
Our data demonstrate that capsaicin may be a useful phyto-
chemical for attenuating obesity-induced inﬂammation and
obesity-related complications.2. Materials and methods
2.1. Adipose tissue culture
Adipose tissues were isolated from obese mice fed 45% high-fat diet
(Research Diets, Inc., New Brunswick, NJ) for 3 months. The adipose
tissues were minced into fragments less than 10 mg in weight and cul-
tured as previously described [20]. All subsequent procedures were per-
formed in a laminar ﬂow hood. In brief, 50 mg of minced adipose tissue
fragments was seeded in 2 ml of M199 medium with 1% fatty acid-free
albumin in each well of a 6-well plate for 3 h to remove blood cells and
soluble factors from the tissue surface. The plate containing the tissue
fragments was placed in a humidiﬁed incubator at 37 C in 5% CO2
atmosphere. After 30 min, the tissue fragments (50 mg/well) were trea-
ted with or without capsaicin (Tocris, CA, USA) for 24 h in serum-free
M199 medium. Aliquots of the culture medium were stored at 80 C
until use, and the adipose tissue fragments were immediately frozen in
liquid nitrogen and stored at 80 C for RNA extraction.
2.2. Primary adipocyte culture
Adipose tissues were cut with scissors into small pieces and digested
with 1 mg/ml collagenase type 2 (Sigma, NY, USA) for 1 h at 37 C.
The digest was ﬁltered through a 100-lm nylon mesh and adipocytes
were isolated by centrifugation at 1500 rpm for 5 min. Fifty microliters
of the isolated adipocytes was seeded in 2 ml of M199 medium in each
well of a 24-well plate. The plate containing the adipocytes was placed
in a humidiﬁed incubator at 37 C in 5% CO2. The adipocytes were
treated with or without capsaicin and/or troglitazone (Cayman, MI,
USA) for 24 h in serum-free M199 medium.
2.3. Preparation of mesenteric adipose tissue-conditioned medium
Male C57BL/6 mice (8 weeks, Hyochang Ltd., Daegu, Korea) were
fed a 45% high-fat diet for 3 months, and mesenteric adipose tissue
(n = 6) was isolated. All subsequent procedures were performed under
a laminar ﬂow hood. Adipose tissue was minced into fragments less
than 10 mg in weight and cultured as previously described [20]. In
brief, 50 mg of minced adipose tissue fragments was seeded in 2 ml
of serum medium in each well of a 6-well plate. The plate containing
the tissue fragments was placed in a humidiﬁed incubator at 37 C
and 5% CO2. The medium was supplemented with glutamine,
25 mM HEPES, 50 lg/ml gentamicin and 0.5 lg/ml amphotericin B.
The tissue culture was incubated for 72 h. Aliquots of the culture med-
ium were stored at 80 C until the use.
2.4. RAW264.7 and 3T3-L1 adipocyte culture
The murine macrophage cell line RAW 264.7 was obtained from a
Korean cell Line Bank (KCLB40071, Seoul, Korea). The cells were
cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM) supple-
mented with 10% bovine serum, 10 mg/l penicillin–streptomycin (Gib-
co BRL, NY, USA), and 2 mg/l gentamicin (Gibco BRL, NY, USA) at
37 C in 5% CO2. 3T3-L1 preadipocytes (ATCC, USA) were cultured
in a basal medium consisting of DMEM supplemented with 200 lM
ascorbic acid, 10% fetal bovine serum, 10 mg/l penicillin–streptomycin,
and 2 mg/l gentamicin at 37 C in 5% CO2 atmosphere. Two days after
reaching conﬂuence, the cells were incubated in a diﬀerentiation med-
ium containing an inducing mixture (0.25 lM dexamethasone, 10 lg/
ml insulin, and 0.5 mM 1-methyl-3-isobutylxanthine) in the basal med-
ium. After 40–42 h, the cell culture medium was changed to a matura-
tion medium, which is the basal medium containing 5 lg/ml insulin.
The maturation medium was changed every two days for 6 days.
2.5. Measurement of MCP-1, IL-6, adiponectin, and TNF-a
concentrations
The levels of MCP-1, IL-6, adiponectin, and TNF-a in culture
supernatants were assessed by enzyme-linked immunosorbent assay(ELISA). The assay was conducted utilizing an OptEIA mouse
MCP-1 set, a mouse TNF-a set (BD Biosciences Pharmingen, CA,
USA), a mouse IL-6 set (R&D systems, MN, USA), or a mouse adipo-
nectin set (R& D systems, MN, USA). The sample was thawed, appro-
priately diluted with assay diluent, and assayed. The levels of MCP-1,
IL-6, adiponectin, and TNF-a were quantiﬁed from a standard curve
obtained using the SOFTmax curve-ﬁtting program (Molecular
Devices, CA, USA).
2.6. RT-PCR analysis
Total RNA was extracted from 100 mg of a tissue sample using a tri-
reagent kit (MCR Inc., USA). Total RNA (0.5 lg) was used for reverse
transcription; it was ampliﬁed using a polymerase chain reaction
(PCR) technique in a single reaction, using an Access RT-PCR system
according to the manufacturer’s instructions in a TaKaRa Thermal cy-
cler (TaKaRa Biomedicals, Tokyo, Japan). For semiquantitative anal-
ysis, the linearity of the ampliﬁcations of MCP-1, IL-6, adiponectin,
COX-2, and 36B4 cDNAs was established in preliminary experiments.
The following sets of primers were used in the PCR ampliﬁcation:
MCP-1 (GeneBank accession number: NM011333), forward 5 0-
TCAGCCAGATGCAGTTAACGC-30, reverse 5 0-TGGATGCAT-
TAGCTTCAGATTCAGATTTACG-30; IL-6 (NM011333), forward
5 0-CATGTTCTCTGGGAAATCGTGG-30, reverse 5 0-AACTGATA-
TGCTTAGGCATAACGCAC-3 0, adiponectin (NM011333), forward
5 0-TACAACCAACAGAATCATTATGACGG-3 0, reverse 5 0-GAA-
AGCCAGTAAATGTAGAGTCGTGTTGA-3 0, 36B4(BC011291),
forward 5 0-TGTGTGTCTGCAGATCGGGTAC-3 0, reverse 5 0-
CTTGGCGGGATTAGTCGAAG-30, COX-2 (M949 67), forward
5 0-CAGTTTTTCAAGACAGATCATAAGCG-3 0, reverse 5 0-TGCT-
CCTGCTTGAGATGTCG-3 0. The conditions for PCR for the target
genes were as follows: MCP-1 gene: 40 cycles at 85 C for 1 min, 58 C
for 1 min, and 72 C for 1 min; IL-6 gene: 38 cycle at 85 C for 30 s,
51 C for 30 s, and 72 C for 30 s; adiponectin gene: 40 cycles at
85 C for 1 min, 64 C for 1 min, and 72 C for 1 min; COX-2 gene:
30 cycle at 85 C for 1 min, 42 C for 1 min, and 72 C for 1 min.
Ampliﬁcation products obtained by PCR were electrophoretically sep-
arated on a 2% agarose gel. SYBR green-stained bands corresponding
to the target genes and 36B4 were photographed with a DS-34 Polar-
oid camera. The intensity of the bands was densitometrically measured
with an NIH Image analyzer. All MCP-1, IL-6, COX-2, and adiponec-
tin signals were normalized to the mRNA level of the housekeeping
gene 36B4 and expressed as a ratio.
2.7. Migration assay
The migration of macrophages was assessed in a multiwell micro-
chemotaxis chamber (Neuro Probe Inc., Gaithersburg, MD, USA).
Brieﬂy, the above prepared RAW264.7 cells were suspended in M199
medium at 1 · 106 cells/ml and 27 ll was placed in the upper wells of
a 96-well chamber that was separated from lower well by an 8 lm-
polycarbonate ﬁlter containing adipose tissue-conditioned medium
with or without capsaicin and/or MCP-1 (R&D systems, MN, USA).
After incubation for 6 h at 37 C, non-migrated cells were removed
by scraping them out and cells that migrated across the ﬁlter were ﬁxed
and stained with Diﬀ-Quik (Merck Corp, Darmstadt, Germany).
Stained cells were counted under a light microscopy in three randomly
chosen high-power ﬁelds (HPF; 400·). Results are expressed as the
mean ± S.E.M. of triplicate samples.
2.8. Measurement of amount of nitric oxide
The amount of nitric oxide in cell-free culture supernatants was mea-
sured using Griess reagent [30]. Brieﬂy, 100 ll of supernatant was
mixed with an equal volume of Griess reagent on a 96-well ﬂat-bottom
plate. The absorbance at 570 nm was measured after 10 min using a
micro-ELISA reader. The amount of nitrite was calculated from the
NaNO2 standard curve.2.9. Measurement of NF-jB binding activity
Nuclear extract from treated 3T3-L1 adipocytes was prepared with a
Nuclear Extract kit (Active Motif, Rixensart, Belgium) and the protein
content in the nuclear lysate was determined using a BCA protein kit
(Pierce, Rockford IL, USA). The DNA binding activity of the p65 sub-
unit of NF-jB in the nuclear protein extract was determined by NF-jB
p65 TransAM assay according to the manufacturer’s protocol. Brieﬂy,
oligonucleotides containing NF-jB consensus sequence was immobi-
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tein extracts (15 lg/sample) for 1 h at room temperature with gentle
agitation, washed and incubated with antibodies against p65 for 1 h
without agitation. After successive washing, the plate was incubated
with diluted horseradish peroxidase-conjugated secondary antibodies
for 1 h. The peroxidase activity was visualized using a developing solu-
tion placed in the wells of the plate for 5 min, and the absorbance at
450 nm was measured using a micro-ELISA reader.
2.10. Animal treatment
Male C57BL/6 mice (8 weeks) were fed a 45% high-fat diet for 6
weeks. The mice fed a high-fat diet were injected by intraperitoneal
administration of capsaicin (2 mg/kg, BW, dissolved in 0.9% saline with
2% ethanol, 10% tween 80, i.p. injection) or vehicle (0.9% saline with 2%
ethanol, 10% tween 80) only for control [31] ﬁve times for 10 days.
2.11. Flow cytometric analysis
Stromal vascular cells were isolated from adipose tissues. Brieﬂy,
adipose tissues were cut with scissors into small pieces and digested
with 1 mg/ml collagenase type 2 for 1 h at 37 C. The digest was ﬁltered
through a 100 lm-nylon mesh and stromal vascular fraction cells were
isolated by centrifugation at 1500 rpm for 5 min. Stromal vascular cells
were incubated in the dark at 4 C on a bidirectional shaker for 30 min
in Fc blocking solution (eBioscience, CA, USA), then stained with
phycoerythrin-conjugated antimouse F4/80 (eBioscience, CA, USA)
and/or ﬂuorescein isothiocyanate-conjugated antimouse CD11b (eBio-
science, CA, USA). After incubation with the antibodies, 1 ml of ﬂow
cytometric analysis (FACS) buﬀer was added to the cells. Cells were
centrifuged at 1200 rpm for 5 min and resuspended in 1 ml of FACS
buﬀer. The wash was repeated two times. Cells were analyzed on a
FACSCalibur (BD Biosciences, CA, USA) with CellQuest software
(BD Biosciences, CA, USA).
2.12. Statistical analyses
Results are expressed as means ± S.E.M. Statistical analysis was per-
formed using ANOVA and Duncan’s multiple-range test. Diﬀerences
were considered to be signiﬁcant when P < 0.05.3. Results
3.1. Eﬀects of capsaicin on expression of adipokine mRNA and
protein release from mesenteric adipose tissue of obese mice
Body weight of obese mice was 40.1 ± 0.56 g, and their mes-
enteric and epididymal fat tissue weights were 1.05 ± 0.10 gMCP-1
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Fig. 1. Eﬀect of capsaicin on expressions of adipokines (i.e., MCP-1, IL-6, an
Mesenteric adipose tissues (50 mg/well) were treated with or without capsaicin
was measured by RT-PCR. (A) MCP-1, (B) IL-6 and (C) adiponectin mRN
bands was densitometrically measured and normalized to the mRNA express
experiments. Values are means ± S.E.M. *P < 0.05, **P < 0.01, signiﬁcantlyand 2.21 ± 0.06 g, respectively. Visceral fat displays more
enhanced lipolytic activity and inﬂammatory phenotypes than
other fat depots, and thus is more implicated in the develop-
ment of obesity-related complication than other fat depots
[19]. Our previous study and others have demonstrated that
mesenteric adipose tissue has the greatest potential to release
MCP-1 and to induce macrophage inﬁltration among other
adipose tissues (e.g. subcutaneous, epididymal, renal) [20,32].
To examine the eﬀect of capsaicin on the productions of adipo-
kines (MCP-1, IL-6 and adiponectin), mesenteric adipose tis-
sues from obese mice were cultured with or without
capsaicin, and the expression levels of the genes encoding these
adipokines and protein released were measured by RT-PCR or
ELISA. Capsaicin signiﬁcantly inhibited the expressions of
MCP-1 and IL-6 mRNAs and protein release in the mesenteric
adipose tissues of obese mice (Figs. 1A, B, 2A, and B), whereas
it signiﬁcantly enhanced the expression of adiponectin mRNA
and protein release in the mesenteric adipose tissues (Figs. 1C
and 2C).
3.2. Eﬀect of capsaicin on release of adipokine proteins from
adipocytes isolated from obese mice
To examine whether capsaicin alters adipokine (IL-6, MCP-
1, and adiponectin) releases from adipocytes, we isolated
adipocytes from adipose tissues of obese mice and treated
the adipocytes with or without capsaicin. Peroxisome prolifer-
ator-activated receptor gamma (PPARc) agonist, troglitazone,
signiﬁcantly inhibited MCP-1 and IL-6 production, and
enhanced adiponectin production from adipocytes (Fig. 3A,
B, and C). Capsaicin signiﬁcantly inhibited the releases of
MCP-1 and IL-6 (Fig. 3A and B) in adipocytes isolated from
the adipose tissues of obese mice, whereas it signiﬁcantly en-
hanced adiponectin (Fig. 3C) release from the adipocytes mim-
icking troglitazone action. Simultaneous treatment with both
capsaicin (50 lM) and troglitazone (10 lM) resulted in greater
inhibition (58%, 90%) on MCP-1 and IL-6 production from
adipocytes when it was compared with the single treatment
of capsaicin (24%, 18%) or troglitazone (27%, 26%) alone at
the same concentration.**
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Fig. 2. Eﬀects of capsaicin on expressions of adipokines (i.e., MCP-1, IL-6, and adiponectin) and protein release from mesenteric adipose tissues of
obese mice. Mesenteric adipose tissues (50 mg/well) were treated with or without capsaicin (0–100 lM) and incubated for 24 h. Levels of adipokines
protein release in the culture medium was measured by ELISA. Levels of (A) MCP-1, (B) IL-6 and (C) adiponectin protein releases in mesenteric
adipose tissues. Data represent results of three independent experiments. Values are means ± S.E.M. *P < 0.05, **P < 0.01, signiﬁcantly diﬀerent from
control.
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Fig. 3. Eﬀects of capsaicin on releases of adipokines (i.e., MCP-1, IL-6, and adiponectin) from adipocytes isolated from visceral adipose tissues of
obese mice. Isolated adipocytes were cultured with or without capsaicin or troglitazone, as described in Section 2. The levels of MCP-1 (A), IL-6 (B),
and adiponectin (C) were measured by ELISA. Values are means ± S.E.M. All results shown are representative of results of three independent
experiments. *P < 0.05, **P < 0.01, signiﬁcantly diﬀerent from control.
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induced by obese mice mesenteric adipose tissue-conditioned
medium or MCP-1
Our previous study showed that adipose tissue-derivedMCP-
1 plays a crucial role in macrophage inﬁltration into the adipose
tissues of obese mice; thus, MCP-1 is closely associated with the
enhanced inﬂammatory response in the adipose tissues of obese
mice [20]. To test whether capsaicin can alter adipose tissue-
derived MCP-1 action, we prepared a mesenteric adipose tissue
culture-conditioned medium containing chemotactic factors
such as MCP-1 and treated macrophages with it to induce
macrophage migration. The mesenteric adipose tissue-derived
conditioned medium enhanced RAW264.7 macrophage
migration, and capsaicin markedly suppressed RAW264.7
macrophage migration induced by the mesenteric adipose
tissue-conditioned medium (Fig. 4A). In addition, capsaicin
also inhibited MCP-1-induced macrophage migration in a
dose-dependent manner (Fig. 4B).3.4. Inhibitory eﬀect of capsaicin on macrophage activation
stimulated by treatment with mesenteric adipose tissue-
conditioned medium
To examine whether capsaicin suppresses adipose tissue
macrophage activation, macrophages were treated with the
mesenteric adipose tissue-conditioned medium with or without
capsaicin, and the productions of proinﬂammatory mediators
(nitric oxide, TNF-a, and MCP-1) were measured by ELISA.
Themesenteric adipose tissue-conditionedmedium signiﬁcantly
inducedRAW264.7macrophages to release nitric oxide, TNF-a
and MCP-1, and capsaicin markedly decreased the proinﬂam-
matory mediator productions from the macrophage treated
with mesenteric adipose tissue-conditioned medium (Fig. 5).
RT-PCR analysis revealed that the expression of hypoxia-
inducible factor-1 alpha, a marker of hypoxia, was not altered
in the adipose tissue during the preparation of the adipose tis-
sue-conditioned medium for 24 h (data not shown), indicating
that the incubation process did not initiate a hypoxic shock.
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Fig. 4. Inhibitory eﬀect of capsaicin on macrophage migration induced by obese mesenteric adipose tissue-conditioned medium (MT-CM) or MCP-
1. RAW 264.7 cells were placed in the upper wells of a 96-well culture chamber that were separated from the lower wells containing diﬀerent adipose
tissue-conditioned media or MCP-1, and incubated for 6 h at 37 C. The cells that migrated across the ﬁlter were ﬁxed and stained with Diﬀ-Quick,
and counted under a light microscope in three randomly chosen high-power ﬁelds. Values are means ± S.E.M. from three independent experiments.
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Fig. 5. Inhibitory eﬀect of capsaicin on macrophage activation induced by obese mesenteric adipose tissue-conditioned medium. RAW 264.7 cells
were stimulated with the obese mesenteric adipose tissue-conditioned medium and incubated for 24 h with or without capsaicin (30–100 lM). The
amount of MCP-1 or TNF-a released in culture medium was measured by ELISA. The amount of nitrite was determined using Griess reagent and
the standard curve constructed using NaNO2 in the culture medium. (A) MCP-1 protein release, (B) TNF-a protein release, and (C) nitric oxide
release. Values are means ± S.E.M. Representative results of four independent experiments are shown. *P< 0.05, signiﬁcantly diﬀerent from control.
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Fig. 6. Inhibitory eﬀect of capsaicin on NF-jB activation induced by
adipose tissue-conditioned medium in 3T3-L1 adipocytes. 3T3-L1
adipocytes were treated with and without macrophage-conditioned
medium (M/-CM), and adipose tissue-conditioned medium and
incubated for 18 h with and without capsaicin. Nuclear proteins were
extracted from 3T3-L1 adipocytes. NF-jB activation in adipocyte
nuclear extract was determined using p65 TransAM assay as described
in Section 2. *P < 0.05, **P < 0.01, signiﬁcantly diﬀerent from control.
J.-H. Kang et al. / FEBS Letters 581 (2007) 4389–4396 43933.5. Inhibitory eﬀect of capsaicin on NF-jB activation in 3T3-L1
adipocytes induced by adipose tissue-conditioned medium or
macrophage-conditioned medium
The inductions of the inﬂammatory gene, TNF-a, IL-6, and
adiponectin are regulated by the transcription factor NF-jB.
To examine whether capsaicin action is associated with the
NF-jB pathway, we investigated whether capsaicin inhibits
the DNA binding activity of NF-jB subunit p65 in adipocytes
treated with a macrophage-conditioned medium or an adipose
tissue-conditioned medium. As shown in Fig. 6, the DNA
binding activity of NF-jB subunit p65 in adipocyte nuclear
protein extract, which was markedly increased by the macro-
phage-conditioned medium and adipose tissue-conditioned
medium, signiﬁcantly decreased in the adipocytes treated with
capsaicin, indicating that capsaicin suppresses the DNA bind-
ing activity of NF-jB.
3.6. Eﬀects of capsaicin on expression of adipokine genes and
macrophage markers from mesenteric adipose tissue of
obese mice
We further examined whether capsaicin in vivo modulates
adipokines production and suppresses macrophage migration
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4394 J.-H. Kang et al. / FEBS Letters 581 (2007) 4389–4396into adipose tissue. C57BL/6 mice (male, 8 weeks) were fed a
high-fat diet for 6 weeks, and treated with capsaicin (i.p. injec-
tion, 2 mg/kg, BW) for 10 days. Our result revealed that the
expression levels of MCP-1 and IL-6 decreased in the adipose
tissue of the obese mice treated with capsaicin compared with
those of the control (Fig. 8A and B). Consistent with this, the
expression level of cyclooxygenase-2 (COX-2), which increases
under inﬂammatory conditions, signiﬁcantly decreased in the
adipose tissue of capsaicin-treated obese mice compared with
that of the control (Fig. 8C). The expression level of adiponec-
tin, anti-inﬂammatory adipokine, markedly increased in the
adipose tissue of capsaicin-treated obese mice compared with
that of the control (Fig. 8D). Moreover, FACS revealed that
macrophage population (F4/80+/CD11b+) signiﬁcantly de-
creased in the adipose tissue of the obese mice treated with
capsaicin compared with that of the control (Fig. 9). These0
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Fig. 8. Eﬀects of capsaicin on expressions of MCP-1, IL-6, COX-2, and adiponectin genes in adipose tissue of obese mice. Adipose tissue was isolated
from the obese mice injected with (n = 4) or without (n = 4) capsaicin solution (2 mg/kg, BW). The expression levels of MCP-1 (A), IL-6 (B), COX-2
(C), and adiponectin (D) genes were measured by RT-PCR. The intensity of the bands was densitometrically measured and normalized to the mRNA
expression levels of the 36B4 gene. Values are means ± S.E.M. *P < 0.05, **P < 0.01, signiﬁcantly diﬀerent from control.
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Fig. 7. Chemical structure of capsaicin (8-methyl-N-vanillyl-6-non-
enamide).
CD11b
Fig. 9. Decreased macrophage numbers in adipose tissue of obese mice
treated with capsaicin. Stromal vascular fraction was isolated from the
visceral adipose tissue of the obese mice injected with (n = 4) or
without (n = 4) capsaicin solution (2 mg/kg, BW). The levels of CD11b
and F4/80 were measured by FACS as described in Section 2.
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duced inﬂammatory phenotypes by modulating adipokine re-
leases and inhibitingmacrophage inﬁltration into adipose tissue.4. Discussion
This study demonstrated that capsaicin, a naturally occur-
ring anti-inﬂammatory phytochemical, can improve the dys-
regulation of adipokine production from and macrophage
behavior in obese adipose tissues.
Capsaicin (8-methyl-N-vanillyl-6-nonenamide) consists of
three main sections, a lipophilic alkyl chain at one end, con-
nected via an acyl-amide linkage to the vanillyl group bearing
the polar hydroxyl group at the other end of the molecule
(Fig. 7) [33]. Capsaicin has been shown to bind to speciﬁc
vanilloid receptor-1 (VR-1) on the membrane of sensory neu-
rons, leading to activation of a cation channel and inducing
depolarization and Ca2+ inﬂux [33]. However, in non-neuronal
cells such as macrophages, capsaicin action can occur through
NF-jB pathway not by a VR-1-mediated one [29].
The dysregulation of adipokine release, which causes obes-
ity-induced inﬂammation, is the common denominator that
links obesity to the pathogenesis of insulin resistance and ath-
erosclerosis [10]. Among adipokines, we targeted IL-6, MCP-1,
and adiponectin, which are implicated in obesity-related
pathologies such as type II diabetes and atherosclerosis [34].
Interestingly, capsaicin decreased the levels of IL-6 and
MCP-1 and increased the level of adiponectin released from
obese fat tissues and fat cells. This dual action of capsaicin
may be favorable for improving the dysregulation of adipokine
release through the normalization of the balance between the
secretions of proinﬂammatory and anti-inﬂammatory adipo-
kines in insulin resistance or atherosclerosis.
The expression levels of macrophage speciﬁc markers such
as CD68 and F4/80 are upregulated in genetically and diet-
induced obese mice [19]. Therefore, adipose tissue macro-
phages are considered to be crucial for obesity-induced
inﬂammation. Proinﬂammatory adipokines such as IL-6 and
MCP-1 also activate macrophages [13]. We have previously
shown that adipose tissue-derived MCP-1 induces macrophage
accumulation into the adipose tissues of obese mice and stim-
ulates macrophages to produce proinﬂammatory mediators
[20]. Our current data demonstrated that capsaicin signiﬁ-
cantly inhibits the macrophage migration induced by MCP-1
and the mesenteric adipose tissue-conditioned medium, and
that capsaicin also signiﬁcantly suppresses macrophage activa-
tion to produce inﬂammatory mediators such as nitric oxide,
TNF-a, and MCP-1 induced by the obese-mouse mesenteric
adipose tissue-conditioned medium. These ﬁndings suggest
that capsaicin has potential to suppress the inﬂammatory
response ampliﬁed by adipose tissue macrophages in obesity.
Several lines of evidence suggest that ligands for PPARc
such as thiazolidinediones (TZDs), which are used as antidia-
betic drugs, suppress TNF-a, IL-6, and MCP-1 gene expres-
sions and protein release, and enhance adiponectin release
[35]. Previously, we showed that capsaicin can act as a PPARc
ligand, resulting in the inhibition of TNF-a production by
LPS-stimulated macrophages [36]. We observed that PPARc
ligand, troglitazone, signiﬁcantly inhibited MCP-1 and IL-6
production, and enhanced adiponectin production from adipo-
cytes. Therefore, the dual action of suppressing IL-6 andMCP-1 releases and enhancing adiponectin release from obese
adipose tissues and adipocytes may be due to the ligand action
of capsaicin for PPARc. It has also been shown that PPARc
ligands inhibit monocyte/macrophage chemotaxis and activa-
tion [36,37], indicating that the inhibitory action of capsaicin
on macrophage behavior in our observation is also associated
with its ligand action for PPARc.
The molecular events that involve inﬂammation include the
activation of proinﬂammatory transcription factor NF-jB, be-
sides PPARc. Troglitazone, a PPARc ligand, has been shown
to suppress intranuclear NF-jB activation and increase cellu-
lar IjB level in leukocytes [38]. We previously showed that
capsaicin inhibits the NF-jB pathway by inhibiting IjB degra-
dation in LPS-stimulated macrophages, leading to the suppres-
sion of the release of proinﬂammatory mediators [29]. In this
study, we conﬁrmed that NF-jB in 3T3-L1 adipocytes could
be activated by a mesenteric adipose tissue-derived condi-
tioned medium or a macrophage-derived conditioned medium,
and that NF-jB activation in these adipocytes is signiﬁcantly
inhibited by capsaicin. These ﬁndings taken together strongly
suggest that PPARc and NF-jB are involved in the inhibitory
action of capsaicin on the release of inﬂammatory adipokines
such as IL-6 and MCP-1.
We further investigated whether capsaicin can be applied to
the suppression of obesity-induced inﬂammatory responses
in vivo. It has been shown that intraperitoneal injection of cap-
saicin (6 mg/kg, BW) in vivo alters lipid energy metabolism
[31] and dietary capsaicin supplementation (0.014%) lowers
the perirenal adipose tissue weight and levels of serum triglyc-
eride in obese rats [39]. Our data demonstrated that intraperi-
toneal injection of capsaicin (2 mg/kg, BW) signiﬁcantly
decreased the expression levels of MCP-1, IL-6, and COX-2
genes in the adipose tissue of obese mice, but increased the
expression level of adiponectin gene. Moreover, there was a
signiﬁcant decrease in macrophage inﬁltration into the adipose
tissue of the obese mice. These results indicate that the beneﬁ-
cial dual action of capsaicin in vitro can be relevant in vivo.
In summary, capsaicin suppressed the expressions of the IL-
6 and MCP-1 genes and protein release from the obese adipose
tissues and isolated adipocytes, whereas it enhanced the
expressions of the adiponectin gene and the protein release.
Moreover, capsaicin inhibited macrophage migration induced
by the obese mesenteric adipose tissue-conditioned medium
or MCP-1, and inhibits macrophage activation to release pro-
inﬂammatory mediators. Our ﬁndings suggest that capsaicin
suppresses obesity-induced inﬂammation by modulating
adipokines release. Thus, capsaicin may be a useful phyto-
chemical for attenuating obesity-induced inﬂammation and
obesity-related pathologies.
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